ArticleACP journal club

Review: adding cytotoxic drugs to a chemotherapy regimen increases tumor response rates and toxicity, but not survival in metastatic breast cancer.

James Khatcheressian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.